DownSyndrome Achieves Completes Delivery of Biosamples for Study Investigating Prevalence of Eye Disease in People with DS

DownSyndrome Achieves is pleased to announce it has completed the delivery of 100 blood plasma and serum samples for an NIH-funded R21 study on keratoconus dystrophy (KD) and Down syndrome at the University of North Texas Health Science Center at Fort Worth.Keratoconus dystrophy is a corneal disease that affects more...

DownSyndrome Achieves 2022 Board Retreat

Amazing weekend retreat with our Board of Directors at DownSyndrome Achieves. So grateful for this amazing team, and for their excitement, dedication, and commitment to accelerating and enabling research for people with Down syndrome. If you have a family member living with Down syndrome, please email dsabiobank@downsyndrome-achieves.websitepro.hosting to learn more...

Breakthroughs Begin With You

Our 5-year goal at DSA is to collect up to 500 blood specimens and related health data from individuals with DS and their immediate families. These samples are crucial to advancing translational research that will yield improved diagnostics and therapies for people with DS.


Please join us in making a contribution to help us reach our goal!